Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
CEY | Ann: Removal from Official List at close 30/11/20 | 30/11/10 | 0 | 1.6K | |||
|
|||||||
CEY | Ann: Domestic Contract Discussions Cease | 11/11/10 | 0 | 1.1K | |||
|
|||||||
CEY | Ann: Non-Executive Director Change | 04/11/10 | 0 | 1.1K | |||
|
|||||||
CEY | thanks | 02/11/10 | 0 | 1.2K | |||
|
|||||||
CEY | Ann: Ceasing to be a substantial holder | 01/11/10 | 0 | 1.1K | |||
|
|||||||
CEY | got your cheque yet? | 06:36 | 1 | 1.7K | |||
|
|||||||
CEY | Ann: Quarterly Activities Report - September 2010 | 29/10/10 | 0 | 782 | |||
|
|||||||
CEY | Ann: Suspension from Official Quotation at close | 28/10/10 | 0 | 579 | |||
|
See All Discussions